Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamal Solanki

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Rheumatology (Oxford, England)|January 10, 2015
Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?Fiona M McQueen, Kamal Solanki
International Journal of Rheumatic Diseases|August 14, 2010
A can of red herringsRafi Raja, Duncan Lamont, Anthony Yung, et al.
The New Zealand Medical Journal|June 29, 2015
Retention on anti-tumour necrosis factor therapy: the Waikato experienceKen Ip, Lorraine Hartley, Kamal Solanki, et al.
International Journal of Rheumatic Diseases|September 22, 2022
Direct and indirect health-related costs of systemic sclerosis in New ZealandSree Deepika Padala, Chunhuan Lao, Kamal Solanki, et al.
The New Zealand Medical Journal|October 13, 2004
Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritisKamal Solanki, Myfanwy Spellerberg, Peter Chapman, et al.
International Journal of Rheumatic Diseases|June 6, 2017
Mortality in the Waikato Hospital Systemic Sclerosis CohortClement Ooi, Kamal Solanki, Chunhuan Lao, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|May 19, 2022
A case of IgG4-related retroperitoneal fibrosis with significant involvement of the abdominal aorta-a clinical and diagnostic challengeSinead Gormley, Paola Tacuri Bravo, Xavier Kos, et al.
Journal of Scleroderma and Related Disorders|December 16, 2024
Hospitalizations in patients with systemic sclerosis: Differences between limited and diffuse cutaneous subtypesPhilippa van Dantzig, Chunhuan Lao, Sree Deepika Padala, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 24, 2015
Development of a Multidimensional Additive Points System for Determining Access to Rheumatology ServicesDouglas White, Kamal Solanki, Vicki Quincey, et al.
Seminars in Arthritis and Rheumatism|July 30, 2024
Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New ZealandKe Li Chow, Paula Elizabeth Keating, Kamal Solanki, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Rheumatology (Oxford, England)|January 10, 2015
Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?Fiona M McQueen, Kamal Solanki
International Journal of Rheumatic Diseases|August 14, 2010
A can of red herringsRafi Raja, Duncan Lamont, Anthony Yung, et al.
The New Zealand Medical Journal|June 29, 2015
Retention on anti-tumour necrosis factor therapy: the Waikato experienceKen Ip, Lorraine Hartley, Kamal Solanki, et al.
International Journal of Rheumatic Diseases|September 22, 2022
Direct and indirect health-related costs of systemic sclerosis in New ZealandSree Deepika Padala, Chunhuan Lao, Kamal Solanki, et al.
The New Zealand Medical Journal|October 13, 2004
Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritisKamal Solanki, Myfanwy Spellerberg, Peter Chapman, et al.
International Journal of Rheumatic Diseases|June 6, 2017
Mortality in the Waikato Hospital Systemic Sclerosis CohortClement Ooi, Kamal Solanki, Chunhuan Lao, et al.
Journal of Vascular Surgery Cases and Innovative Techniques|May 19, 2022
A case of IgG4-related retroperitoneal fibrosis with significant involvement of the abdominal aorta-a clinical and diagnostic challengeSinead Gormley, Paola Tacuri Bravo, Xavier Kos, et al.
Journal of Scleroderma and Related Disorders|December 16, 2024
Hospitalizations in patients with systemic sclerosis: Differences between limited and diffuse cutaneous subtypesPhilippa van Dantzig, Chunhuan Lao, Sree Deepika Padala, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 24, 2015
Development of a Multidimensional Additive Points System for Determining Access to Rheumatology ServicesDouglas White, Kamal Solanki, Vicki Quincey, et al.
Seminars in Arthritis and Rheumatism|July 30, 2024
Anti-HMGCR myopathy: Diversity of clinical presentations in a national cohort in New ZealandKe Li Chow, Paula Elizabeth Keating, Kamal Solanki, et al.
Pageof 2